Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1704-2026Class II

Brand Name: Finesse BTK Multicath Product Name: Injectable Angioplasty Balloon Catheter Model/Catalog Number...

Summa Therapeutics, LLC / initiated 2025-07-21 / Open, Classified / root cause: manufacturing process

SUMMA THERAPEUTICS, LLC began a recall of Brand Name: Finesse BTK Multicath Product Name: Injectable Angioplasty Balloon Catheter Model/Catalog Number: FS252251502 Product Description: 5 French sheath... on . FDA classified it as Class II and gives the reason as "Potential for the balloon in the device to not meet burst specifications". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-1704-2026
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Summa Therapeutics, LLC
Product
Brand Name: Finesse BTK Multicath Product Name: Injectable Angioplasty Balloon Catheter Model/Catalog Number: FS252251502 Product Description: 5 French sheath, 0.014" guidewire compatible over-the-wire injectable angioplasty balloon catheter, balloon diameter 2.5mm, balloon length 225mm, catheter working length 150cm Component: NA
Product code
LIT Catheter, Angioplasty, Peripheral, Transluminal
Reason for recall
Potential for the balloon in the device to not meet burst specifications.
Root cause tag
manufacturing process
FDA root cause
Process control
Action
On July 21, 2025, customers were notified via E-mail. We discovered that the burst test values recorded did not meet the specification of the safety rated burst test average of 17atm. Please review your inventory and we ask that these catheters be returned for further investigation.
Quantity in commerce
22 units
Distribution
US Nationwide distribution in the states of New Jersey, Florida.
Product codes and lots
Model/Catalog Number: FS252251502; UDI-DI: 00810017490967; lots: 240502, 240095, 231296, 231296A and 240095A;

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1704-2026
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1704-2026Class IIOngoingVoluntary: Firm initiated